Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Aerovate Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,835
    Market Cap (Jan-05-2024)
    0.568 Billion USD
    World Rank (Jul-30-2023)
    12,989
    Market Cap (Jul-30-2023)
    0.481 Billion USD
    World Rank (Dec-25-2022)
    10,461
    Market Cap (Dec-25-2022)
    0.687 Billion USD
    World Rank (Jan-07-2022)
    17,917
    Market Cap (Jan-07-2022)
    0.24 Billion USD
    Headquarters Country
    USA
    Company Website
    AEROVATE THERAPEUTICS, INC.

  2. PetIQ Inc.

    World Rank (Jan-05-2024)
    11,950
    Market Cap (Jan-05-2024)
    0.558 Billion USD
    World Rank (Jul-30-2023)
    13,043
    Market Cap (Jul-30-2023)
    0.477 Billion USD
    World Rank (Dec-25-2022)
    16,363
    Market Cap (Dec-25-2022)
    0.272 Billion USD
    World Rank (Jan-07-2022)
    12,394
    Market Cap (Jan-07-2022)
    0.59 Billion USD
    Annual Revenue in USD
    932 Million USD
    Annual Net Income in USD
    -15 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Animals healthcare company with headquarters is in Idaho, USA
    Company Website
    PETIQ INC

  3. Biomea Fusion Inc.

    World Rank (Jan-05-2024)
    12,072
    Market Cap (Jan-05-2024)
    0.546 Billion USD
    World Rank (Jul-30-2023)
    10,266
    Market Cap (Jul-30-2023)
    0.753 Billion USD
    World Rank (Dec-25-2022)
    17,307
    Market Cap (Dec-25-2022)
    0.228 Billion USD
    World Rank (Jan-07-2022)
    18,155
    Market Cap (Jan-07-2022)
    0.23 Billion USD
    Headquarters Country
    USA
    Company Website
    BIOMEA FUSION, INC.

  4. Tyra Biosciences Inc.

    World Rank (Jan-05-2024)
    12,081
    Market Cap (Jan-05-2024)
    0.544 Billion USD
    World Rank (Jul-30-2023)
    11,471
    Market Cap (Jul-30-2023)
    0.611 Billion USD
    World Rank (Dec-25-2022)
    15,805
    Market Cap (Dec-25-2022)
    0.296 Billion USD
    World Rank (Jan-07-2022)
    13,416
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -59 Million USD
    Annual Net Income in USD
    -55 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Website
    Tyra Biosciences, Inc.

  5. ARS Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    12,116
    Market Cap (Jan-05-2024)
    0.541 Billion USD
    World Rank (Jul-30-2023)
    10,896
    Market Cap (Jul-30-2023)
    0.673 Billion USD
    World Rank (Dec-25-2022)
    9,907
    Market Cap (Dec-25-2022)
    0.758 Billion USD
    Headquarters Country
    USA
    Company Website
    ARS PHARMACEUTICALS, INC.

  6. Longboard Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    12,173
    Market Cap (Jan-05-2024)
    0.535 Billion USD
    World Rank (Jul-30-2023)
    19,005
    Market Cap (Jul-30-2023)
    0.168 Billion USD
    World Rank (Dec-25-2022)
    24,041
    Market Cap (Dec-25-2022)
    0.063 Billion USD
    World Rank (Jan-07-2022)
    23,871
    Market Cap (Jan-07-2022)
    0.08 Billion USD
    Headquarters Country
    USA
    Company Website
    LONGBOARD PHARMACEUTICALS, INC.

  7. Ocular Therapeutix

    World Rank (Jan-05-2024)
    12,314
    Market Cap (Jan-05-2024)
    0.523 Billion USD
    World Rank (Jul-30-2023)
    14,969
    Market Cap (Jul-30-2023)
    0.350 Billion USD
    World Rank (Dec-25-2022)
    17,875
    Market Cap (Dec-25-2022)
    0.206 Billion USD
    World Rank (Jan-07-2022)
    13,549
    Market Cap (Jan-07-2022)
    0.49 Billion USD
    Annual Revenue in USD
    43 Million USD
    Annual Net Income in USD
    -6 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Ocular Therapeutix is a Biopharmaceutical Platform company focused on the formulation, development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel based formulation technology. The company annual revenue is 12.3 million USD and 167 employees as on 2019. The headquarters is in USA.
    Company Website
    OCULAR THERAPEUTIX

  8. Phathom Pharmaceuticals

    World Rank (Jan-05-2024)
    12,344
    Market Cap (Jan-05-2024)
    0.521 Billion USD
    World Rank (Jul-30-2023)
    9,683
    Market Cap (Jul-30-2023)
    0.835 Billion USD
    World Rank (Dec-25-2022)
    12,820
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    13,041
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -172 Million USD
    Annual Net Income in USD
    -197 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Phathom Pharmaceuticals is a Clinical Stage Biopharmaceutical company committed to transforming the treatment landscape and improving the lives of patients suffering from acid related gastrointestinal (GI) disorders. The company annual revenue is approximately 74.5 million USD, total assets is 263.9 million USD and 16 employees as on 2019. The headquarters is in USA.
    Company Website
    PHATHOM PHARMACEUTICALS

  9. Replimune Group

    World Rank (Jan-05-2024)
    12,365
    Market Cap (Jan-05-2024)
    0.520 Billion USD
    World Rank (Jul-30-2023)
    7,950
    Market Cap (Jul-30-2023)
    1.172 Billion USD
    World Rank (Dec-25-2022)
    7,081
    Market Cap (Dec-25-2022)
    1.332 Billion USD
    World Rank (Jan-07-2022)
    8,400
    Market Cap (Jan-07-2022)
    1.22 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -118 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Replimune Group is an emerging class of Cancer Therapeutics company that exploits the ability of viruses to selectively replicate in and kill tumors while at the same time inducing a potent, patient specific, anti tumor immune response. The headquarters is in USA.

    Facts About Company

    Replimune Group Annual Net loss for year ending Mar-2023 was -174 million USD.

    Replimune Group Annual Net loss for year ending Mar-2022 was -118 million USD.

    As on 2023, Replimune Group has 284 employees.

    Company Website
    REPLIMUNE GROUP

  10. IGM Biosciences Inc.

    World Rank (Jan-05-2024)
    12,531
    Market Cap (Jan-05-2024)
    0.506 Billion USD
    World Rank (Jul-30-2023)
    13,336
    Market Cap (Jul-30-2023)
    0.455 Billion USD
    World Rank (Dec-25-2022)
    10,131
    Market Cap (Dec-25-2022)
    0.728 Billion USD
    World Rank (Jan-07-2022)
    10,633
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -165 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    IGM Biosciences is a Biotechnology company. The headquarters is in USA.
    Company Website
    IGM BIOSCIENCES

Share